Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. reports developments across its consumer cannabis business, including retail dispensary openings, medical and adult-use product brands, quarterly operating results, and international expansion. The company trades on the Toronto Stock Exchange as CURA and on OTCQX as CURLF.
Recurring updates cover brands such as Curaleaf, Select, Grassroots, Find, Dark Heart, Anthem, and Four 20 Pharma; U.S. dispensary activity; medical cannabis distribution in Germany and other international markets; share repurchase activity; board and shareholder matters; and regulatory topics affecting cannabis operations.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has announced that it will report its financial results for Q4 and the fiscal year ending December 31, 2020, on March 9, 2021. The company will host a conference call at 4:30 p.m. ET for a discussion on operational and financial highlights. Curaleaf operates in 23 states with 101 dispensaries and a workforce of over 3,800 employees. The results are anticipated to provide investors with insights into the company’s performance in the growing cannabis market.
Summary not available.
Summary not available.
Curaleaf has opened its second dispensary in St. Petersburg, Florida, marking its 34th location in the state and 98th nationwide. This expansion aims to meet the growing demand for medical cannabis, with Florida's sales reaching $1.2 billion in 2020. The new dispensary offers a variety of premium products, including Select, America's top oil brand. Curaleaf is committed to providing quality patient care and education, encouraging both new and returning patients to visit their locations.
Curaleaf Holdings, Inc. (CURLF) has launched its new Live Blends vape cartridges in Florida, which feature a unique formulation of live and botanical terpenes. This innovative product aims to enhance the flavor and effects for medical cannabis patients. Each cartridge combines strain-specific Solventless Terpene Extract with a micro-infusion of botanical terpenes, providing a clean and broad spectrum of cannabis compounds. As the first market for Live Blends, Florida serves a growing medical patient base, with over 420,000 registered patients and around 5,000 new patients weekly.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a top cannabis operator in the U.S., announced that Executive Chairman Boris Jordan will present the keynote at the Benzinga Virtual Cannabis Capital Conference on October 15, 2020. The session will be moderated by Benzinga CEO Jason Raznick. Curaleaf's management will also hold virtual investor meetings on the same day, which can be accessed through their investor relations website. Curaleaf operates in 23 states, with 95 dispensaries and over 30 processing sites, employing more than 3,000 individuals.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is expanding its footprint in Florida by opening two new dispensaries in the Florida Panhandle: Curaleaf Pensacola on October 15 and Curaleaf Panama City on October 16. These locations aim to enhance access to medical cannabis for patients in the area, contributing to Curaleaf's goal of serving over 420,000 registered patients in Florida. Furthermore, the company is set to begin harvesting from its new cultivation center, with innovative products launching in November.
Curaleaf announced the rebranding of its recently acquired Arrow Alternative Care and Grassroots dispensaries in Connecticut to Curaleaf branding. The company, a leading cannabis operator in the U.S., aims to strengthen its market position by aligning these locations with its national brand strategy. Curaleaf operates four dispensaries in the state and has expanded its product offerings, including its top-ranked Select brand. The rebranding underscores Curaleaf's commitment to quality and customer satisfaction, with an emphasis on enhancing community relationships.
Curaleaf has launched its new NANO Drops in Florida, utilizing innovative nanoemulsion technology for enhanced cannabinoid delivery. This product aims to provide customers with a faster onset and more efficient dosing method compared to traditional tinctures. Curaleaf's Select brand recently generated $1 million in sales in just one month. The NANO Drops deliver a 5MG THC dose per 1ML and are available in unflavored, lime, and grapefruit options. This launch complements Curaleaf's existing product line and reflects its commitment to customer choice in cannabis consumption.
Curaleaf Holdings announced its third quarter financial results for 2020 will be reported after market close on November 17, 2020. The conference call is scheduled for 4:30 p.m. ET the same day, featuring operational and financial highlights, followed by a Q&A session. For those unable to attend, a replay will be available until November 24. Curaleaf operates in 23 states with over 93 dispensaries and employs more than 3,000 individuals, committed to enhancing cannabis clarity and consumption confidence.